VERTEX PHARMACEUTICALS INC / MA Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for November 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 573,600 | |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 44,700 | |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 48,188 | |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 117.75 | 400 | 47,100 | 338,895 | 339.3 K to 338.9 K (-0.12 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 116.65 | 1,300 | 151,645 | 339,295 | 340.6 K to 339.3 K (-0.38 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 115.42 | 2,300 | 265,466 | 340,595 | 342.9 K to 340.6 K (-0.67 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 114.53 | 2,700 | 309,231 | 342,895 | 345.6 K to 342.9 K (-0.78 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 113.53 | 3,800 | 431,414 | 345,595 | 349.4 K to 345.6 K (-1.09 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Nov 21 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Nov 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Horton Kenneth L | EVP & Chief Legal O ... | Gift | G | 0.00 | 410 | 0 | 72,053 | 72.5 K to 72.1 K (-0.57 %) |
Nov 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 111.97 | 134 | 15,004 | 78,671 | 78.8 K to 78.7 K (-0.17 %) |
Nov 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 111.93 | 33 | 3,694 | 43,350 | 43.4 K to 43.4 K (-0.08 %) |
Nov 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 111.87 | 153 | 17,116 | 34,895 | 35 K to 34.9 K (-0.44 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 578,000 | |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 46,000 | |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 52,988 | |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 116.64 | 1,900 | 221,616 | 338,895 | 340.8 K to 338.9 K (-0.56 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 116.16 | 7,700 | 894,432 | 340,795 | 348.5 K to 340.8 K (-2.21 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 114.81 | 900 | 103,329 | 348,495 | 349.4 K to 348.5 K (-0.26 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Nov 14 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 45.11 | 1,687 | 76,101 | 15,188 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 114.29 | 100 | 11,429 | 17,000 | 17.1 K to 17 K (-0.58 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 112.93 | 700 | 79,051 | 17,100 | 17.8 K to 17.1 K (-3.93 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 112.07 | 887 | 99,406 | 17,800 | 18.7 K to 17.8 K (-4.75 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 45.11 | 1,687 | 76,101 | 18,687 | 17 K to 18.7 K (+9.92 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 29.84 | 9,900 | 295,416 | 0 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 115.21 | 9,900 | 1,140,579 | 21,210 | 31.1 K to 21.2 K (-31.82 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 29.84 | 9,900 | 295,416 | 31,110 | 21.2 K to 31.1 K (+46.68 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Option Exercise | M | 45.11 | 937 | 42,268 | 8,438 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 114.31 | 100 | 11,431 | 34,895 | 35 K to 34.9 K (-0.29 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 113.13 | 200 | 22,626 | 34,995 | 35.2 K to 35 K (-0.57 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Sell | S | 112.07 | 637 | 71,389 | 35,195 | 35.8 K to 35.2 K (-1.78 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Buy | M | 45.11 | 937 | 42,268 | 35,832 | 34.9 K to 35.8 K (+2.69 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 4,400 | 156,816 | 582,400 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 47,300 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 10.41 | 4,800 | 49,968 | 57,788 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 113.44 | 900 | 102,096 | 338,895 | 339.8 K to 338.9 K (-0.26 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.39 | 6,800 | 764,252 | 339,795 | 346.6 K to 339.8 K (-1.96 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 111.55 | 2,800 | 312,340 | 346,595 | 349.4 K to 346.6 K (-0.80 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 4,400 | 156,816 | 349,395 | 345 K to 349.4 K (+1.28 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 344,995 | 343.7 K to 345 K (+0.38 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 10.41 | 4,800 | 49,968 | 343,695 | 338.9 K to 343.7 K (+1.42 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 4,250 | 191,718 | 60,875 | |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 113.98 | 300 | 34,194 | 117,264 | 117.6 K to 117.3 K (-0.26 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 112.98 | 1,374 | 155,235 | 117,564 | 118.9 K to 117.6 K (-1.16 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 112.07 | 2,576 | 288,692 | 118,938 | 121.5 K to 118.9 K (-2.12 %) |
Nov 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 4,250 | 191,718 | 121,514 | 117.3 K to 121.5 K (+3.62 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 29.84 | 100 | 2,984 | 9,900 | |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 29.84 | 10,000 | 298,400 | 10,000 | |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | M | 34.32 | 20,000 | 686,400 | 0 | |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 111.86 | 100 | 11,186 | 21,210 | 21.3 K to 21.2 K (-0.47 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 29.84 | 100 | 2,984 | 21,310 | 21.2 K to 21.3 K (+0.47 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 115.45 | 100 | 11,545 | 21,210 | 21.3 K to 21.2 K (-0.47 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 114.23 | 4,400 | 502,612 | 21,310 | 25.7 K to 21.3 K (-17.11 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 113.47 | 3,200 | 363,104 | 25,710 | 28.9 K to 25.7 K (-11.07 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 112.47 | 2,300 | 258,681 | 28,910 | 31.2 K to 28.9 K (-7.37 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 29.84 | 10,000 | 298,400 | 31,210 | 21.2 K to 31.2 K (+47.15 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 112.80 | 2,684 | 302,755 | 21,210 | 23.9 K to 21.2 K (-11.23 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Sell | S | 112.03 | 17,316 | 1,939,911 | 23,894 | 41.2 K to 23.9 K (-42.02 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | M | 34.32 | 20,000 | 686,400 | 41,210 | 21.2 K to 41.2 K (+94.30 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Grant | A | 0.01 | 40,000 | 400 | 78,671 | 38.7 K to 78.7 K (+103.44 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 37.86 | 1,125 | 42,593 | 5,625 | |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 38.80 | 937 | 36,356 | 938 | |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 113.09 | 100 | 11,309 | 17,000 | 17.1 K to 17 K (-0.58 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 111.97 | 1,962 | 219,685 | 17,100 | 19.1 K to 17.1 K (-10.29 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 37.86 | 1,125 | 42,593 | 19,062 | 17.9 K to 19.1 K (+6.27 %) |
Nov 05 2014 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 38.80 | 937 | 36,356 | 17,937 | 17 K to 17.9 K (+5.51 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.88 | 2,400 | 270,912 | 172,589 | 175 K to 172.6 K (-1.37 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.05 | 50,240 | 5,629,392 | 174,989 | 225.2 K to 175 K (-22.31 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 114.19 | 400 | 45,676 | 225,229 | 225.6 K to 225.2 K (-0.18 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 113.38 | 6,100 | 691,618 | 225,629 | 231.7 K to 225.6 K (-2.63 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 112.41 | 42,922 | 4,824,862 | 231,729 | 274.7 K to 231.7 K (-15.63 %) |
Nov 04 2014 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 111.74 | 25,349 | 2,832,497 | 274,651 | 300 K to 274.7 K (-8.45 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 75,000 | 750 | 119,868 | 44.9 K to 119.9 K (+167.16 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Grant | A | 0.01 | 20,000 | 200 | 43,350 | 23.4 K to 43.4 K (+85.65 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Horton Kenneth L | EVP & Chief Legal O ... | Grant | A | 0.01 | 40,000 | 400 | 72,463 | 32.5 K to 72.5 K (+123.22 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Connolly Thomas | SVP, Human Resource ... | Grant | A | 0.01 | 20,000 | 200 | 34,895 | 14.9 K to 34.9 K (+134.27 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 75,000 | 750 | 84,500 | 9.5 K to 84.5 K (+789.47 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Grant | A | 0.01 | 75,000 | 750 | 117,264 | 42.3 K to 117.3 K (+177.46 %) |